Company
Headquarters: New Taipei City, Taiwan
Employees: 163
CEO: Mr. P. H. Huang
TW$3.18 Billion
TWD as of July 1, 2024
US$97.8 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures and sells pharmaceutical materials and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. The company was incorporated in 1966 and is based in New Taipei City, Taiwan.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Johnson Chemical Pharmaceutical Works Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 4747 wb_incandescent